Author:
Labidi Aymen,Jebali Sami,Safta Mehdi,El Atrache Latifa Latrous
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Min GK, Min JK, Eunhee J, Bong KY (2017) Meta-analysis of the efficacy and safety of grazoprevir and elbasvir for the treatment of Hepatitis C Virus infection. Korean J Clin Pharm 5:4
2. Hussien A, Abdelrahman IA, Amr M, Attia A, Arwa M, Ahmed N, Mohamed MAD (2018) Meta-analysis of grazoprevir plus elbasvir for treatment of Hepatitis C virus genotype 1 infection. Ann Hepatol. https://doi.org/10.5604/01.3001.0010.7532
3. Debbeche R, Said Y, Temime HB, El Jery K, Bouzaïdi S, Salem M (2013) Taoufik Najjar Epidémiologie de l’hépatite C en Tunisie. La Tunisie Medicale 91(02):86–91
4. Mohamed EK, Tamer E, Yasmeen AEL, Gamal E (2016) Elbasvir and grazoprevir for chronic hepatitis C genotypes 1 and 4. Expert Rev Clin Pharmacol. https://doi.org/10.1080/17512433.2016.1233813
5. Thierno D, Delphine C, Françoise D, Anne A, Loïc G (2016) Infection par le virus de l’hépatite C: prise en charge thérapeutique. Presse Med. https://doi.org/10.1016/j.lpm.2016.02.006
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献